Emergent Biosolutions (EBS)

Emergent BioSolutions Inc. (EBS) Q3 2022 Earnings Call Transcript
Nov. 9, 2022 | Source: Seeking Alpha

Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q2 2022 Results - Earnings Call Transcript
Aug. 2, 2022 | Source: Seeking Alpha

Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q1 2022 Results - Earnings Call Transcript
April 29, 2022 | Source: Seeking Alpha

Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q4 2021 Results - Earnings Call Transcript
Feb. 25, 2022 | Source: Seeking Alpha

Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q3 2021 Results - Earnings Call Transcript
Nov. 5, 2021 | Source: Seeking Alpha

Emergent Biosolutions' (EBS) CEO Bob Kramer on Q2 2021 Results - Earnings Call Transcript
July 30, 2021 | Source: Seeking Alpha

Emergent BioSolutions, Inc. (EBS) CEO Robert Kramer on Q1 2021 Results - Earnings Call Transcript
April 30, 2021 | Source: Seeking Alpha

Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q4 2020 Results - Earnings Call Transcript
Feb. 19, 2021 | Source: Seeking Alpha

Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q3 2020 Results - Earnings Call Transcript
Nov. 6, 2020 | Source: Seeking Alpha

Emergent BioSolutions, Inc. (EBS) CEO Bob Kramer on Q2 2020 Results - Earnings Call Transcript
July 31, 2020 | Source: Seeking Alpha

Emergent BioSolutions, Inc. (EBS) CEO Bob Kramer on Q1 2020 Results - Earnings Call Transcript
May 2, 2020 | Source: Seeking Alpha

Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q4 2019 Results - Earnings Call Transcript
Feb. 21, 2020 | Source: Seeking Alpha

Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q3 2019 Results - Earnings Call Transcript
Nov. 7, 2019 | Source: Seeking Alpha

Emergent BioSolutions, Inc. (EBS) CEO Bob Kramer on Q2 2019 Results - Earnings Call Transcript
Aug. 3, 2019 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Bob Kramer on Q1 2019 Results - Earnings Call Transcript
May 3, 2019 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q4 2018 Results - Earnings Call Transcript
Feb. 21, 2019 | Source: Seeking Alpha

Emergent BioSolutions Inc. (EBS) CEO Dan Abdun Nabi on Q3 2018 Results - Earnings Call Transcript
Nov. 1, 2018 | Source: Seeking Alpha

Emergent BioSolutions Inc. (EBS) CEO Dan Abdun-Nabi on Acquisition of Adapt Pharma and its Flagship
Aug. 29, 2018 | Source: Seeking Alpha

Emergent BioSolutions, Inc (EBS) CEO Dan Abdun Nabi on Q2 2018 Results - Earnings Call Transcript
Aug. 2, 2018 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun Nabi on Q1 2018 Results - Earnings Call Transcript
May 3, 2018 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun Nabi on Q4 2017 Results - Earnings Call Transcript
Feb. 22, 2018 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi Hosts Analyst & Investor Day Conference (Transcript
Dec. 8, 2017 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q3 2017 Results - Earnings Call Transcript
Nov. 3, 2017 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Daniel Abdun-Nabi on Q2 2017 Results - Earnings Call Transcript
Aug. 5, 2017 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q1 2017 Results - Earnings Call Transcript
May 7, 2017 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun Nabi on Q4 2016 Results - Earnings Call Transcript
Feb. 23, 2017 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun Nabi on Q3 2016 Results - Earnings Call Transcript
Nov. 8, 2016 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q2 2016 Results - Earnings Call Transcript
Aug. 4, 2016 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Daniel Abdun-Nabi on Q1 2016 Results - Earnings Call Transcript
May 8, 2016 | Source: Seeking Alpha

Emergent BioSolutions (EBS) Q4 2015 Results - Earnings Call Webcast
Feb. 25, 2016 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q4 2015 Results - Earnings Call Transcript
Feb. 25, 2016 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q3 2015 Results - Earnings Call Transcript
Nov. 8, 2015 | Source: Seeking Alpha

Emergent BioSolutions (EBS) Q3 2015 Results - Earnings Call Webcast
Nov. 5, 2015 | Source: Seeking Alpha

Emergent BioSolutions (EBS) Q2 2015 Results - Earnings Call Webcast
Aug. 6, 2015 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Daniel Abdun-Nabi on Q2 2015 Results - Earnings Call Transcript
Aug. 6, 2015 | Source: Seeking Alpha

Emergent BioSolutions (EBS) Q1 2015 Results - Earnings Call Webcast
May 7, 2015 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Daniel Abdun-Nabi on Q1 2015 Results - Earnings Call Transcript
May 7, 2015 | Source: Seeking Alpha

Emergent BioSolutions (EBS) Q4 2014 Results - Earnings Call Webcast
March 5, 2015 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q4 2014 Results - Earnings Call Transcript
March 5, 2015 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q3 2014 Results - Earnings Call Transcript
Nov. 6, 2014 | Source: Seeking Alpha

Emergent BioSolutions (EBS) Q3 2014 Results - Earnings Call Webcast
Nov. 6, 2014 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q2 2014 Results - Earnings Call Transcript
Aug. 9, 2014 | Source: Seeking Alpha

Emergent BioSolutions (EBS) Q2 2014 Results - Earnings Call Webcast
Aug. 7, 2014 | Source: Seeking Alpha

Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q1 2014 Results - Earnings Call Transcript
May 8, 2014 | Source: Seeking Alpha

Emergent BioSolutions' CEO Discusses Q4 2013 Results - Earnings Call Transcript
March 6, 2014 | Source: Seeking Alpha

Emergent BioSolutions CEO Presents at JPMorgan Healthcare Conference (Transcript)
Jan. 14, 2014 | Source: Seeking Alpha

Emergent BioSolutions' Management Presents at Credit Suisse Healthcare Conference (Transcript)
Nov. 13, 2013 | Source: Seeking Alpha

Emergent BioSolutions' CEO Discusses Q3 2013 Results - Earnings Call Transcript
Nov. 9, 2013 | Source: Seeking Alpha

Emergent BioSolutions Inc. Discusses Q3 2013 Results (Webcast)
Nov. 7, 2013 | Source: Seeking Alpha

Emergent BioSolutions' CEO Discusses Q2 2013 Results - Earnings Call Transcript
Aug. 5, 2013 | Source: Seeking Alpha

Emergent's CEO Hosts the 2013 Annual Meeting of Stockholders Conference (Transcript)
May 23, 2013 | Source: Seeking Alpha

Emergent BioSolutions' Management Presents at Bank of America Merrill Lynch 2013 Health Care Confer
May 16, 2013 | Source: Seeking Alpha

Emergent Biosolutions Management Presents at Cowen Health Care Conference (Transcript)
May 10, 2013 | Source: Seeking Alpha

Emergent BioSolutions' CEO Discusses Q1 2013 Results - Earnings Call Transcript
May 3, 2013 | Source: Seeking Alpha

Emergent Biosolutions CEO Discusses Acquisition of HPPD (Transcript)
April 26, 2013 | Source: Seeking Alpha

Emergent's CEO Discusses Q4 2012 Results - Earnings Call Transcript
March 7, 2013 | Source: Seeking Alpha

Emergent BioSolutions' CEO Presents at 31st Annual J.P. Morgan Healthcare Conference (Transcript)
Jan. 8, 2013 | Source: Seeking Alpha

Emergent Biosolutions CEO Discusses Q3 2012 Results - Earnings Call Transcript
Nov. 1, 2012 | Source: Seeking Alpha

Emergent BioSolutions' Management Presents at Wedbush 2012 Life Sciences Management Access Conferen
Aug. 14, 2012 | Source: Seeking Alpha

Emergent BioSolutions' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Aug. 2, 2012 | Source: Seeking Alpha

Emergent BioSolutions' CEO Hosts Annual Shareholder Meeting Conference (Transcript)
May 17, 2012 | Source: Seeking Alpha

Emergent BioSolutions CEOs Discuss 1Q 2012 Results - Earnings Call Transcript
May 4, 2012 | Source: Seeking Alpha

Emergent BioSolutions' Management Presents at Lazard Capital Markets Healthcare Conference 2011 (Tr
March 14, 2012 | Source: Seeking Alpha

Emergent BioSolutions Management Presents at JPMorgan SMid Cap Conference (Transcript)
March 13, 2012 | Source: Seeking Alpha

Emergent Biosolutions' CEO Discusses Q4 2011 Results - Earnings Call Transcript
March 8, 2012 | Source: Seeking Alpha

Emergent BioSolutions' President Presents at the 30th Annual J.P. Morgan Healthcare Conference (Tra
Jan. 10, 2012 | Source: Seeking Alpha

Emergent BioSolutions' CEO Discusses Q3 2011 Results - Earnings Call Transcript
Nov. 3, 2011 | Source: Seeking Alpha

Emergent BioSolutions' CEO Discusses Q2 2011 Results - Earnings Call Transcript
Aug. 4, 2011 | Source: Seeking Alpha

Emergent BioSolutions CEO Discusses Q1 2011 Results - Earnings Call Transcript
May 5, 2011 | Source: Seeking Alpha

Emergent BioSolutions CEO Discusses Q4 2010 Results - Earnings Call Transcript
March 10, 2011 | Source: Seeking Alpha

Emergent BioSolutions CEO Discusses Q3 2010 Results – Earnings Call Transcript
Nov. 5, 2010 | Source: Seeking Alpha

Emergent BioSolutions Inc. Q2 2010 Earnings Call Transcript
Aug. 5, 2010 | Source: Seeking Alpha

Emergent BioSolutions Inc. Q1 2010 Earnings Call Transcript
May 5, 2010 | Source: Seeking Alpha

Emergent BioSolutions Inc. Q4 2009 Earnings Call Transcript
March 4, 2010 | Source: Seeking Alpha

Emergent BioSolutions Inc. Q3 2009 Earnings Call Transcript
Nov. 5, 2009 | Source: Seeking Alpha

Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript
Aug. 6, 2009 | Source: Seeking Alpha

Emergent BioSolutions Inc., Q1 2009 Earnings Call Transcript
May 7, 2009 | Source: Seeking Alpha

Emergent BioSolutions Inc. Q4 2008 Earnings Call Transcript
March 6, 2009 | Source: Seeking Alpha

Emergent BioSolutions Inc. Q3 2008 Earnings Call Transcript
Nov. 21, 2008 | Source: Seeking Alpha

Emergent BioSolutions Inc. Q2 2008 Earnings Call Transcript
Aug. 7, 2008 | Source: Seeking Alpha

Emergent BioSolutions Inc. Q1 2008 Earnings Call Transcript
May 7, 2008 | Source: Seeking Alpha

Emergent Biosolutions Inc. Q4 2007 Earnings Call Transcript
March 7, 2008 | Source: Seeking Alpha

Emergent Biosolutions Q3 2007 Earnings Call Transcript
Nov. 2, 2007 | Source: Seeking Alpha

Emergent BioSolutions: The Wall Street Analyst Forum Presentation Transcript
Aug. 20, 2007 | Source: Seeking Alpha

Recent filings

BlackRock, Inc. just provided an update on share ownership of Emergent Biosolutions - Jan. 20, 2023

SVP of Emergent Biosolutions just declared owning 9,376 shares of Emergent Biosolutions - Jan. 18, 2023

Statement of acquisition of beneficial ownership by individuals - Jan. 10, 2023

Results of Operations and Financial - Jan. 9, 2023

Regulation FD - Jan. 5, 2023

EVP of Emergent Biosolutions just picked up 56,180 shares - Dec. 13, 2022

EVP of Emergent Biosolutions just picked up 96,310 shares - Dec. 13, 2022

Regulation FD - Dec. 6, 2022

Emergent Biosolutions director just disposed of 1,912 shares - Nov. 29, 2022

EVP of Emergent Biosolutions just disposed of 416 shares - Nov. 15, 2022

Emergent Biosolutions Just Filed Its Quarterly Report: Net income (loss) pe... - Nov. 9, 2022

Emergent Biosolutions Reports Financial Results For Third Quarter 2022 - Nov. 8, 2022

Completion of Acquisition or Disposition of Assets - Sept. 26, 2022

On August - Aug. 12, 2022

Emergent Biosolutions Reports Financial Results For Second Quarter 2022 - Aug. 1, 2022

Emergent Biosolutions director just picked up 11,852 shares - July 22, 2022

Emergent Biosolutions director just declared 0 ownership of the company. - July 22, 2022

Departure of Directors or Certain - July 6, 2022

Emergent Biosolutions director just disposed of 1,173 shares - June 13, 2022

Termination of Material Definitive - June 7, 2022

On July - June 6, 2022

Emergent Biosolutions director just picked up 8,446 shares - May 31, 2022

Emergent Biosolutions director just picked up 8,446 shares - May 31, 2022

Emergent Biosolutions director just picked up 8,446 shares - May 31, 2022

Emergent Biosolutions director just picked up 8,446 shares - May 31, 2022

Emergent Biosolutions director just picked up 8,446 shares - May 31, 2022

Emergent Biosolutions director just picked up 8,446 shares - May 31, 2022

Emergent Biosolutions director just picked up 8,446 shares - May 31, 2022

Emergent Biosolutions Inc. 2022 Annual Meeting Of Stockholders May 26, 2022 - May 27, 2022

Emergent Biosolutions director just disposed of 1,996 shares - May 25, 2022

Current report, items 1.01 and 9.01 - May 18, 2022

Emergent Biosolutions Reports Financial Results For First Quarter 2022 - April 28, 2022

Emergent: Form, Schedule Or Registration Statement No Filing Party: Date Filed: Counts! EMERGENT BIOSOLUTIONS INC. 2022 Annual Meeting - April 15, 2022

Emergent Biosolutions releases salary data. CEO sees compensation rise 9% - April 15, 2022

EVP of Emergent Biosolutions just picked up 11,826 shares - April 12, 2022

Emergent Biosolutions director just picked up 8,595 shares - April 5, 2022

Emergent Biosolutions director just declared 0 ownership of the company. - April 5, 2022

EVP of Emergent Biosolutions just declared 0 ownership of the company. - March 25, 2022

Departure of Directors or Certain - March 23, 2022

The Vanguard Group just provided an update on share ownership of Emergent Biosolutions - March 9, 2022

EVP of Emergent Biosolutions just declared owning 7,250 shares of Emergent Biosolutions - March 3, 2022

EVP of Emergent Biosolutions just picked up 25,377 shares - March 3, 2022

EVP of Emergent Biosolutions just picked up 49,406 shares - March 2, 2022

Emergent Biosolutions's President and CEO just picked up 87,700 shares - March 2, 2022

EVP of Emergent Biosolutions just picked up 47,569 shares - March 2, 2022

EVP of Emergent Biosolutions just picked up 35,689 shares - March 2, 2022

EVP of Emergent Biosolutions just picked up 47,515 shares - March 2, 2022

EVP of Emergent Biosolutions just disposed of 1,499 shares - Feb. 25, 2022

EVP of Emergent Biosolutions just disposed of 1,252 shares - Feb. 25, 2022

EVP of Emergent Biosolutions just disposed of 934 shares - Feb. 25, 2022

EVP of Emergent Biosolutions just disposed of 1,299 shares - Feb. 25, 2022

Emergent Biosolutions's President and CEO just disposed of 331 shares - Feb. 24, 2022

EVP of Emergent Biosolutions just disposed of 462 shares - Feb. 24, 2022

EVP of Emergent Biosolutions just disposed of 248 shares - Feb. 24, 2022

EVP of Emergent Biosolutions just disposed of 144 shares - Feb. 24, 2022

EVP of Emergent Biosolutions just disposed of 358 shares - Feb. 24, 2022

Emergent: Lutions Reports Financial Results For Fourth Quarter 2021 - Feb. 24, 2022

Departure of Directors or Certain - Feb. 22, 2022

Neuberger Berman Investment Advisers LLC just provided an update on share ownership of Emergent Biosolutions - Feb. 11, 2022

The Vanguard Group just provided an update on share ownership of Emergent Biosolutions - Feb. 10, 2022

Statement of acquisition of beneficial ownership by individuals - Feb. 10, 2022

BlackRock, Inc. just provided an update on share ownership of Emergent Biosolutions - Jan. 27, 2022

BlackRock, Inc. just provided an update on share ownership of Emergent Biosolutions - Jan. 26, 2022

Departure of Directors or Certain - Jan. 14, 2022

Emergent Biosolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results - Jan. 10, 2022

The Vanguard Group just provided an update on share ownership of Emergent Biosolutions - Dec. 9, 2021

Emergent Biosolutions director just picked up 3,500,008 shares - Dec. 7, 2021

EVP of Emergent Biosolutions just picked up 3,000 shares - Nov. 15, 2021

On November - Nov. 12, 2021

Emergent Biosolutions Just Filed Its Quarterly Report: Net (loss) income pe... - Nov. 5, 2021

Emergent Biosolutions Reports Financial Results For Third Quarter 2021 - Nov. 4, 2021

Termination of a Material Definitive - Nov. 4, 2021

Entry Into a Material Definitive - Oct. 1, 2021

Financial Statements and - Sept. 9, 2021

Emergent Biosolutions Just Filed Its Quarterly Report: Net income per share... - July 30, 2021

Emergent Biosolutions Reports Financial Results For Second Quarter 2021 - July 29, 2021

Departure of Directors or Certain - July 22, 2021

Entry Into a Material Definitive - July 14, 2021

Securities to be offered to employees in employee benefit plans - June 4, 2021

Statement of changes in beneficial ownership of securities - May 27, 2021

Emergent Biosolutions Inc. 2021 Annual Meeting Of Stockholders 1 May 20, 2021 - May 25, 2021

Emergent Biosolutions director just picked up 5,027 shares - May 24, 2021

Emergent Biosolutions director just picked up 5,027 shares - May 24, 2021

Statement of changes in beneficial ownership of securities - May 24, 2021

Emergent Biosolutions director just picked up 5,027 shares - May 24, 2021

Emergent Biosolutions director just picked up 5,027 shares - May 24, 2021

Statement of changes in beneficial ownership of securities - May 24, 2021

Emergent Biosolutions director just picked up 5,027 shares - May 24, 2021

On May - May 12, 2021

Emergent Biosolutions's President and CEO just disposed of 94 shares - May 11, 2021

EVP of Emergent Biosolutions just disposed of 1,054 shares - May 11, 2021

Statement of changes in beneficial ownership of securities - May 11, 2021

EVP of Emergent Biosolutions just disposed of 305 shares - May 11, 2021

Current report, items 2.02, 7.01, and 9.01 - April 29, 2021

Current report, items 8.01 and 9.01 - April 21, 2021

Emergent BioSolutions - April 19, 2021

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - April 9, 2021

Other definitive proxy statements - April 9, 2021

On April - April 5, 2021

EVP of Emergent Biosolutions just disposed of 159 shares - April 1, 2021

Sorry, no schedule available for this company

Emergent BioSolutions Awarded $379.6 Million Procurement Contract to Supply RSDL© (Reactive Skin Decontamination Lotion Kit) to U.S. Department of Defense - Jan. 5, 2023

Emergent BioSolutions Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for Over-the-Counter NARCAN® (naloxone HCl) Nasal Spray - Dec. 6, 2022

Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vaccine Candidate in Post-Approval Field Efficacy Study Using Model-Guided Approach - Nov. 14, 2022

Emergent BioSolutions Inc. (EBS) Q3 2022 Earnings Call Transcript - Nov. 9, 2022

Emergent BioSolutions Reports Financial Results For Third Quarter 2022 - Nov. 8, 2022

Emergent BioSolutions Presents Data from Phase 2 Study Evaluating Safety and Immunogenicity of Chikungunya Vaccine Candidate in Prior Recipients of Other Alphavirus Vaccines - Nov. 1, 2022

Emergent BioSolutions to Release Third Quarter 2022 Financial Results and Conduct Conference Call on November 8, 2022 - Oct. 18, 2022

Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages - Sept. 26, 2022

Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate - Sept. 6, 2022

Emergent BioSolutions to Participate in Investor Conferences - March 14, 2022

Emergent BioSolutions Initiates Phase 1 Study Evaluating Potential Intranasal Treatment for Cyanide Poisoning - March 11, 2022

Emergent BioSolutions to Release Fourth Quarter 2021 Financial Results and Conduct Conference Call on February 24, 2022 - Feb. 7, 2022

Founder and Executive Chairman of Emergent BioSolutions Announces Retirement - Jan. 14, 2022

Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results - Jan. 9, 2022

Emergent BioSolutions to Participate in Investor Conferences - Jan. 3, 2022

Emergent BioSolutions Announces Initiation of Phase 1 Study Evaluating Its Universal Influenza Vaccine Candidate - Dec. 16, 2021

SiTime Set to Join S&P MidCap 400; Emergent BioSolutions to Join S&P SmallCap 600 - Nov. 22, 2021

Emergent BioSolutions to Release Third Quarter 2021 Financial Results and Conduct a Conference Call on November 4, 2021 - Oct. 18, 2021

Emergent BioSolutions Announces Initiation of Pivotal Phase 3 Study Evaluating the Safety and Immunogenicity of Its Single-Dose Chikungunya Vaccine Candidate, CHIKV VLP - Oct. 15, 2021

Shuman, Glenn & Stecker Investigates Emergent BioSolutions, Inc. - Sept. 21, 2021

 


Feedback